Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT06553443 | Randomised Clinical Trial Comparing Drug-coated Balloon to Plain Balloon for All Peripheral AVF Stenosis | PHASE3 | RECRUITING | 94 | — | — | Jan 4, 2024 | Dec 31, 2029 | Aug 14, 2024 | 1 | Singapore |
Time to next clinically-driven intervention
| Arm | Type | Description |
|---|---|---|
| Drug-coated balloon | EXPERIMENTAL | Ranger drug-coated balloon will be used for all peripheral AVF stenosis. |
| Conventional balloon | ACTIVE_COMPARATOR | Conventional balloon will be used for all peripheral AVF stenosis. |
| Name | Type | Description |
|---|---|---|
| Angioplasty of all peripheral AVF stenosis | DEVICE | All peripheral AVF stenosis are to be treated with the same type of balloon depending on allocation |
Inclusion Criteria: 1. Failing AVF with at least 1 AVF stenosis presenting with any clinical, physiological or haemodynamic abnormalities. Both de novo and recurrent stenosis are accepted. 2. AVF has been used successfully for at least 1 month (non-mature AVF are not allowed). 3. Less than 30% resi...